Goldmet 500mg Tablet SR contains Metformin hydrochloride, an oral antihyperglycemic agent used primarily in the management of type 2 diabetes mellitus. Metformin belongs to the biguanide class and functions by improving glucose tolerance, reducing hepatic glucose production, decreasing intestinal absorption of glucose, and enhancing peripheral glucose uptake and utilization. Goldmet 500mg Tablet SR is a sustained-release formulation designed to provide a gradual release of metformin, thereby minimizing gastrointestinal side effects commonly associated with immediate-release forms and improving patient compliance. It is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes, particularly in overweight patients where diet and exercise alone have not achieved adequate control. The sustained-release mechanism allows for once or twice daily dosing, facilitating better adherence. Goldmet should be used cautiously in patients with renal impairment, hepatic dysfunction, or conditions predisposing to hypoxia, as these may increase the risk of lactic acidosis, a rare but serious adverse effect. Regular monitoring of renal function and blood glucose levels is recommended during therapy. This medication should be used under medical supervision, with appropriate lifestyle modifications to optimize therapeutic outcomes.